Literature DB >> 10981054

Lipid disorders in obesity.

S B Nicholas1.   

Abstract

Obesity is considered a public health problem because it is associated with multiple risk factors that place individuals into a significantly high risk group for coronary heart disease. The cardiovascular dysmetabolic syndrome seen in conjunction with obesity is not only associated with insulin resistance and hypertension but also involves an abnormal metabolism of lipids, which leads to an increased storage of fat and subsequent increase in the atherogenesis process. This article details the dyslipidemia of obesity and its cardiovascular consequences and presents some ways in which it can be managed.

Entities:  

Mesh:

Year:  1999        PMID: 10981054     DOI: 10.1007/s11906-999-0007-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  19 in total

1.  Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group.

Authors:  S W Rabkin; Y Chen; L Leiter; L Liu; B A Reeder
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

2.  Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

Authors:  C J Tack; P Smits; P N Demacker; A F Stalenhoef
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

3.  A positive correlation between energy intake and body mass index in a population of 1312 overweight subjects.

Authors:  J Fricker; F Fumeron; D Clair; M Apfelbaum
Journal:  Int J Obes       Date:  1989

4.  Body weight and risk of nonfatal acute myocardial infarction among women: a case-control study from northern Italy.

Authors:  A Tavani; E Negri; B D'Avanzo; C La Vecchia
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

5.  Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols.

Authors:  C Binnert; C Pachiaudi; M Beylot; D Hans; J Vandermander; P Chantre; J P Riou; M Laville
Journal:  Am J Clin Nutr       Date:  1998-04       Impact factor: 7.045

6.  Effects of 14 d of covert substitution of olestra for conventional fat on spontaneous food intake.

Authors:  J O Hill; H M Seagle; S L Johnson; S Smith; G W Reed; Z V Tran; D Cooper; M Stone; J C Peters
Journal:  Am J Clin Nutr       Date:  1998-06       Impact factor: 7.045

7.  Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

Authors:  P A Hollander; S C Elbein; I B Hirsch; D Kelley; J McGill; T Taylor; S R Weiss; S E Crockett; R A Kaplan; J Comstock; C P Lucas; P A Lodewick; W Canovatchel; J Chung; J Hauptman
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

Review 8.  Human obesity: from lipid abnormalities to lipid oxidation.

Authors:  L F Van Gaal; A Zhang; M M Steijaert; I H De Leeuw
Journal:  Int J Obes Relat Metab Disord       Date:  1995-09

9.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

10.  Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991.

Authors:  R J Kuczmarski; K M Flegal; S M Campbell; C L Johnson
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

View more
  4 in total

1.  Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients.

Authors:  Minpei Kuroda; Yoshihiro Mimaki; Takayuki Ohtomo; Junji Yamada; Tozo Nishiyama; Tatsumasa Mae; Hideyuki Kishida; Teruo Kawada
Journal:  J Nat Med       Date:  2011-10-11       Impact factor: 2.343

2.  Efficacy of Turmeric as Adjuvant Therapy in Type 2 Diabetic Patients.

Authors:  N Maithili Karpaga Selvi; M G Sridhar; R P Swaminathan; R Sripradha
Journal:  Indian J Clin Biochem       Date:  2014-05-08

3.  Association between RBC Indices, Anemia, and Obesity-Related Diseases Affected by Body Mass Index in Iranian Kurdish Population: Results from a Cohort Study in Western Iran.

Authors:  Maryam Kohsari; Mehdi Moradinazar; Zohreh Rahimi; Farid Najafi; Yahya Pasdar; Atefeh Moradi; Ebrahim Shakiba
Journal:  Int J Endocrinol       Date:  2021-09-04       Impact factor: 3.257

4.  Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats.

Authors:  Chris L Schaich; Hossam A Shaltout; K Bridget Brosnihan; Allyn C Howlett; Debra I Diz
Journal:  Physiol Rep       Date:  2014-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.